Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or primary human data
PubMed 36830173 · doi:10.3390/antibiotics12020263
What was done
This narrative review examined diagnostic methods and treatment modalities for small intestinal bacterial overgrowth (SIBO). It reviewed duodenal/jejunal aspirate culture, hydrogen/methane breath tests using carbohydrate substrates, and urinary excretion tests based on chemically synthesized bile acid conjugates (such as PABA-CA, PABA-UDCA, 5-ASA-UDCA, and PABA-UDCA disulfate). It also reviewed therapeutic approaches including antibiotics, probiotics, therapeutic diets, herbal medicines, and fecal microbiota transplantation.
What was found
The abstract reports no quantitative metrics, sensitivity/specificity estimates, or statistical data. It describes aspirate culture as an invasive gold standard, notes breath tests lack sensitivity and specificity depending on patient disease state, and highlights bile acid conjugate urinary excretion tests as useful based on a small number of clinical trials.
Why it matters
The review provides an overview of emerging non-invasive diagnostic options, particularly bile acid conjugate urinary tests, and current management strategies for SIBO.
Limits
As a narrative review without systematic search or meta-analytic methodology, no primary data, patient sample sizes, or quantitative diagnostic accuracy values are reported in the abstract. Clinical trials evaluating urinary excretion tests remain limited in number.
Cited by
- supports Bile salts possess antimicrobial properties that prevent microbes from overgrowing in the small intestine, and low stomach acid impairs bile function.